We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Nerve Regrowth after Heart Transplant

By HospiMedica staff writers
Posted on 18 Jul 2002
Researchers have found that spontaneous nerve regeneration following a heart transplant is more likely in cases involving young donors, young recipients, and fast, uncomplicated surgery. More...
Their study was published in the July 9, 2002, rapid access issue of Circulation.

Nerve regrowth to the left ventricle can improve exercise performance, blood-flow regulation, and ventricular function. It also allows the patient to feel the sensation of chest pain, an important warning sign of coronary blockage. Sympathetic nerve fibers are severed during transplant surgery. Nerve regrowth takes months or years to develop, and some patients never experience it.

The study involved 77 heart transplant patients (23-60 years old) without organ rejection or other severe problems, who were examined with positron emission tomography (PET) to obtain a cross-sectional image of the heart and heart tissue function. Donor age ranged from 13-59. Follow-up occurred from 1.5 years to 19 years after transplantation. In 52 patients, researchers found partial reinnervation, while 25 patients had no evidence of nerve regrowth. Among those with regrowth, nerves were restored in 21% of the left ventricular heart muscle. Reinnervation was greater as more time passed and in hearts from younger donors and in younger recipients. Patients who had shorter surgery had more regrowth. Reinnervation was not shown to affect survival.

"In addition, surgical dissection of the nerves requires nerve fibers to regrow along arteries to reach the new heart,” said Frank M. Bengel, M.D., assistant professor at the Technical University in Munich (Germany) and lead author. "Extensive scar tissue along this path may impede the regrowth. Hence, extensive reinnervation is more likely if there were few complications during transplant surgery.”



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.